Literature DB >> 24089421

Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults.

Kenneth D R Setchell1, Nadine M Brown, Suzanne Summer, Eileen C King, James E Heubi, Sidney Cole, Trish Guy, Bevan Hokin.   

Abstract

S-(-)equol, an intestinally derived metabolite of the soy isoflavone daidzein, is proposed to enhance the efficacy of soy diets. Adults differ in their ability to produce equol when consuming soy foods for reasons that remain unclear. Therefore, we performed a comprehensive dietary analysis of 143 macro- and micronutrients in 159 healthy adults in the United States (n = 89) and Australia (n = 70) to determine whether the intake of specific nutrients favors equol production. Three-d diet records were collected and analyzed using Nutrition Data System for Research software and S-(-)equol was measured in urine by mass spectrometry. Additionally, in a subset of equol producers and nonproducers (n = 10/group), we examined the long-term stability of equol producer status by retesting 12, 18, and 24 mo later. Finally, the effect of oral administration of the antibiotic metronidazole (500 mg/d for 7 d) on equol production was examined in 5 adults monitored during a 4-mo follow-up period. Equol producers accounted for 30.3% and 28.6% of the United States and Australian participants, respectively (overall frequency, 29.6%). No significant differences were observed for total protein, carbohydrate, fat, saturated fat, or fiber intakes between equol producers and nonproducers. However, principal component analysis revealed differences in several nutrients, including higher intakes of polyunsaturated fatty acids (P = 0.039), maltose (P = 0.02), and vitamins A (P = 0.01) and E (P = 0.035) and a lower intake of total cholesterol (P = 0.010) in equol producers. During a 2-y period, equol producer status remained unchanged in all nonproducers and in 80% of equol producers, whereas metronidazole abolished equol production in only 20% of participants. In conclusion, these findings suggest that major differences in the macronutrient content of the diet appear not to influence equol production, but subtle differences in some nutrients may influence the ability to produce equol, which was a relatively stable phenomenon.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24089421      PMCID: PMC3827640          DOI: 10.3945/jn.113.179564

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  65 in total

1.  Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype.

Authors:  Kyung-Won Hong; Kwang-Pil Ko; Younjhin Ahn; Cheong-Sik Kim; Seon-Joo Park; Jae Kyung Park; Sung Soo Kim; Yeonjung Kim
Journal:  Genes Nutr       Date:  2012-04-03       Impact factor: 5.523

2.  Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk.

Authors:  Kenneth D R Setchell; Nadine M Brown; Xueheng Zhao; Stephanie L Lindley; James E Heubi; Eileen C King; Mark J Messina
Journal:  Am J Clin Nutr       Date:  2011-09-28       Impact factor: 7.045

3.  The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers.

Authors:  Claudio Gardana; Enrica Canzi; Paolo Simonetti
Journal:  J Nutr Biochem       Date:  2008-12-13       Impact factor: 6.048

4.  Interaction of phytoestrogens with estrogen receptors alpha and beta.

Authors:  K Morito; T Hirose; J Kinjo; T Hirakawa; M Okawa; T Nohara; S Ogawa; S Inoue; M Muramatsu; Y Masamune
Journal:  Biol Pharm Bull       Date:  2001-04       Impact factor: 2.233

5.  Exposure of infants to phyto-oestrogens from soy-based infant formula.

Authors:  K D Setchell; L Zimmer-Nechemias; J Cai; J E Heubi
Journal:  Lancet       Date:  1997-07-05       Impact factor: 79.321

6.  Urinary phytoestrogen concentrations in the U.S. population (1999-2000).

Authors:  Liza Valentín-Blasini; Melissa A Sadowski; Donna Walden; Lisa Caltabiano; Larry L Needham; Dana B Barr
Journal:  J Expo Anal Environ Epidemiol       Date:  2005-11

7.  Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls.

Authors:  Kyung Bin Song; Charlotte Atkinson; Cara L Frankenfeld; Tuija Jokela; Kristiina Wähälä; Wendy K Thomas; Johanna W Lampe
Journal:  J Nutr       Date:  2006-05       Impact factor: 4.798

8.  Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback.

Authors:  Trent D Lund; Daniel J Munson; Megan E Haldy; Kenneth D R Setchell; Edwin D Lephart; Robert J Handa
Journal:  Biol Reprod       Date:  2003-12-17       Impact factor: 4.285

9.  One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.

Authors:  N Védrine; J Mathey; C Morand; M Brandolini; M-J Davicco; L Guy; C Rémésy; V Coxam; C Manach
Journal:  Eur J Clin Nutr       Date:  2006-02-15       Impact factor: 4.016

10.  Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.

Authors:  Hideyuki Akaza; Naoto Miyanaga; Naomi Takashima; Seiji Naito; Yoshihiko Hirao; Taiji Tsukamoto; Tomoaki Fujioka; Mitsuru Mori; Wun-Jae Kim; Jae Mann Song; Allan J Pantuck
Journal:  Jpn J Clin Oncol       Date:  2004-02       Impact factor: 3.019

View more
  14 in total

1.  Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China.

Authors:  Charlotte Atkinson; Roberta M Ray; Wenjin Li; Ming-Gang Lin; Dao Li Gao; Jackilen Shannon; Helge Stalsberg; Peggy L Porter; Cara L Frankenfeld; Kristiina Wähälä; David B Thomas; Johanna W Lampe
Journal:  Nutr Res       Date:  2016-03-30       Impact factor: 3.315

2.  S-(-)equol production is developmentally regulated and related to early diet composition.

Authors:  Nadine M Brown; Stephanie L Galandi; Suzanne S Summer; Xueheng Zhao; James E Heubi; Eileen C King; Kenneth D R Setchell
Journal:  Nutr Res       Date:  2014-04-05       Impact factor: 3.315

3.  Isoflavone Intake and the Risk of Coronary Heart Disease in US Men and Women: Results From 3 Prospective Cohort Studies.

Authors:  Le Ma; Gang Liu; Ming Ding; Geng Zong; Frank B Hu; Walter C Willett; Eric B Rimm; JoAnn E Manson; Qi Sun
Journal:  Circulation       Date:  2020-03-23       Impact factor: 29.690

Review 4.  The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids.

Authors:  Aedín Cassidy; Anne-Marie Minihane
Journal:  Am J Clin Nutr       Date:  2016-11-23       Impact factor: 7.045

5.  Metabolism of Soy Isoflavones by Intestinal Bacteria: Genome Analysis of an Adlercreutzia Equolifaciens Strain That Does Not Produce Equol.

Authors:  Lucía Vázquez; Ana Belén Flórez; Begoña Redruello; Baltasar Mayo
Journal:  Biomolecules       Date:  2020-06-23

Review 6.  Biomarkers of legume intake in human intervention and observational studies: a systematic review.

Authors:  Pedapati S C Sri Harsha; Roshaida Abdul Wahab; Mar Garcia-Aloy; Francisco Madrid-Gambin; Sheila Estruel-Amades; Bernhard Watzl; Cristina Andrés-Lacueva; Lorraine Brennan
Journal:  Genes Nutr       Date:  2018-09-10       Impact factor: 5.523

7.  Compositional and functional differences in human gut microbiome with respect to equol production and its association with blood lipid level: a cross-sectional study.

Authors:  Wei Zheng; Yue Ma; Ai Zhao; Tingchao He; Na Lyu; Ziqi Pan; Geqi Mao; Yan Liu; Jing Li; Peiyu Wang; Jun Wang; Baoli Zhu; Yumei Zhang
Journal:  Gut Pathog       Date:  2019-05-10       Impact factor: 4.181

8.  Roles of Phytoestrogen in the Pathophysiology of Intracranial Aneurysm.

Authors:  Kimihiko Yokosuka; Caleb Rutledge; Yoshinobu Kamio; Atsushi Kuwabara; Hiroki Sato; Redi Rahmani; James Purcell; Satoru Eguchi; Jacob F Baranoski; Tigran Margaryan; Artak Tovmasyan; Jinglu Ai; Michael T Lawton; Tomoki Hashimoto
Journal:  Stroke       Date:  2021-06-23       Impact factor: 10.170

Review 9.  Helping women to good health: breast cancer, omega-3/omega-6 lipids, and related lifestyle factors.

Authors:  Michel de Lorgeril; Patricia Salen
Journal:  BMC Med       Date:  2014-03-27       Impact factor: 8.775

Review 10.  Addressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction.

Authors:  Claudine Manach; Dragan Milenkovic; Tom Van de Wiele; Ana Rodriguez-Mateos; Baukje de Roos; Maria Teresa Garcia-Conesa; Rikard Landberg; Eileen R Gibney; Marina Heinonen; Francisco Tomás-Barberán; Christine Morand
Journal:  Mol Nutr Food Res       Date:  2016-11-15       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.